Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Lymphoma, B-Cell × avelumab × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Transitional Cell 7 Carcinoma, Merkel Cell 6 Neoplasms 5 Neoplasm Metastasis 5 Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Urinary Bladder Neoplasms 3 Skin Neoplasms 3 Melanoma 3 Carcinoma, Renal Cell 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Ovarian Neoplasms 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Thymoma 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Penile Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neuroendocrine Tumors 1 Motor Activity 1 Microsatellite Instability 1 Lymphoma, B-Cell 1 Endometrial Neoplasms 1

Interventions

Cyclophosphamide 17 Rituximab 13 fludarabine 8 Prednisone 6 Lenalidomide 6 Doxorubicin 6 pirtobrutinib 5 fludarabine phosphate 5 Vincristine 5 Bendamustine Hydrochloride 5 venetoclax 4 Etoposide 4 CT-P10 4 polatuzumab vedotin 3 pembrolizumab 3 ibrutinib 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Immunotherapy, Adoptive 3 liposomal doxorubicin 2 etoposide phosphate 2 acalabrutinib 2 Nivolumab 2 Injections 2 Biopsy 2 zanubrutinib 1 varlilumab 1 tocilizumab 1 tisagenlecleucel 1 tazemetostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡